Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial

BACKGROUND: Remission is the primary objective of treating juvenile idiopathic arthritis (JIA). It is still debatable whether early intensive treatment is superior in terms of earlier achievement of remission. The aim of this study was to evaluate the effectiveness of early etanercept+methotrexate (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Rheumatol Online J
Main Authors: Alexeeva, Ekaterina, Horneff, Gerd, Dvoryakovskaya, Tatyana, Denisova, Rina, Nikishina, Irina, Zholobova, Elena, Malievskiy, Viktor, Santalova, Galina, Stadler, Elena, Balykova, Larisa, Spivakovskiy, Yuriy, Kriulin, Ivan, Alshevskaya, Alina, Moskalev, Andrey
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7788754/
https://ncbi.nlm.nih.gov/pubmed/33407590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-020-00488-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados